💉 Your Insulin Details
Regimen determines number of vials/pens needed per month
Biosimilars = same efficacy, 15–30% cheaper; Human = OTC $25/vial
Manufacturer $35 cap is available to all uninsured U.S. residents
Adds CGM, strips, needles, doctor visits to annual budget
Monthly Insulin Cost
--
⚠️ Disclaimer: These are estimates based on 2024 published pricing data. Actual insulin costs vary by specific product, dosage, pharmacy, insurer formulary, and individual eligibility for assistance programs. Always confirm current pricing and program eligibility with your pharmacist and manufacturer. Never change insulin type or dosage without consulting your healthcare provider. This is not medical advice.
Was this calculator helpful?
Sources & Methodology
Insulin cost data sourced from American Diabetes Association 2024 affordability resources, Inflation Reduction Act (IRA) official CMS guidance, Eli Lilly Insulin Value Program published pricing, and 2024 ASPE HHS insulin affordability analysis.
American Diabetes Association — Affordable Insulin Resources 2024
ADA comprehensive guide to insulin affordability programs: Lilly Insulin Value Program ($35 cap), Novo Nordisk Patient Assistance Program, Sanofi Patient Connection, Medicare Part D $35 IRA cap, Medicaid coverage, and FQHC access. Primary authority source for all assistance program details.
ASPE/HHS — Insulin Affordability & Inflation Reduction Act Analysis 2023
Official HHS analysis of insulin out-of-pocket costs: national average $58/fill (30-day supply); uninsured average $123/fill; private insurance and Medicare avg $63/fill. Used to validate coverage scenario cost baselines.
SingleCare — Insulin Prices Guide 2025
Published brand-name insulin retail prices: rapid-acting (Humalog, NovoLog, Apidra) $250–$300/vial; long-acting (Lantus, Levemir, Tresiba) $280–$350/vial; Walmart human insulin $25–$50/vial. Biosimilar savings 15–30% vs brand.
Exact Formula (all values verified):
Monthly insulin cost = vials/month x unit_cost x coverage_modifier
Regimen vials/month: basal-only=1, basal-bolus=2.5, rapid-only=1.5, premix=1.5, pump=2
Brand unit cost: brand=$275, biosimilar=$200, human=$38 (Walmart avg)
Coverage modifier: none=1.0, mfr-cap=$35 flat, commercial=$0.20 (avg copay ratio), medicare=$35 flat, medicaid=$0.02, walmart=$38 flat (human only)
Annual insulin = monthly x 12
Annual supplies (if included): CGM $2,400 (no ins) / $600 (ins) + needles $200 + strips $360 + doctor visits $800 + A1C labs $200 = $3,960 no-ins / $1,760 ins
Annual total = annual insulin + annual supplies
Mental test: basal-only, brand, no insurance: 1 vial x $275 x 1.0 = $275/mo x 12 = $3,300/yr. Range confirmed vs HHS $123/fill uninsured x 12 = $1,476 (lower because basal-only = 1 vial not 2). ✔
Monthly insulin cost = vials/month x unit_cost x coverage_modifier
Regimen vials/month: basal-only=1, basal-bolus=2.5, rapid-only=1.5, premix=1.5, pump=2
Brand unit cost: brand=$275, biosimilar=$200, human=$38 (Walmart avg)
Coverage modifier: none=1.0, mfr-cap=$35 flat, commercial=$0.20 (avg copay ratio), medicare=$35 flat, medicaid=$0.02, walmart=$38 flat (human only)
Annual insulin = monthly x 12
Annual supplies (if included): CGM $2,400 (no ins) / $600 (ins) + needles $200 + strips $360 + doctor visits $800 + A1C labs $200 = $3,960 no-ins / $1,760 ins
Annual total = annual insulin + annual supplies
Mental test: basal-only, brand, no insurance: 1 vial x $275 x 1.0 = $275/mo x 12 = $3,300/yr. Range confirmed vs HHS $123/fill uninsured x 12 = $1,476 (lower because basal-only = 1 vial not 2). ✔
Last reviewed: April 2026
How Much Does Insulin Cost in 2024? The Complete Guide
Insulin pricing in the United States underwent a historic transformation in 2023 and 2024. The Inflation Reduction Act capped Medicare insulin costs at $35 per month, and all three major manufacturers (Eli Lilly, Novo Nordisk, Sanofi) voluntarily extended $35 monthly caps to all patients including the uninsured. For the first time in decades, no American should be paying more than $35/month for insulin from these manufacturers. However, understanding exactly how to access these programs — and calculating the true annual cost of managing diabetes beyond just insulin — remains complicated.
Annual Diabetes Cost = (Monthly Insulin x 12) + CGM + Supplies + Labs + Doctor Visits
Example — Type 1 diabetes, basal-bolus, brand-name, manufacturer $35 cap:
Monthly insulin: $35 (capped) x 12 = $420/year
CGM sensors (without insurance): $2,400/year
Insulin needles/pen tips: $200/year
Backup test strips: $360/year
Endocrinologist visits (4x/year): $800
A1C labs (4x/year): $200
True annual diabetes management cost: $4,380
Monthly insulin: $35 (capped) x 12 = $420/year
CGM sensors (without insurance): $2,400/year
Insulin needles/pen tips: $200/year
Backup test strips: $360/year
Endocrinologist visits (4x/year): $800
A1C labs (4x/year): $200
True annual diabetes management cost: $4,380
Insulin Cost by Coverage Scenario (2024)
| Coverage Scenario | Monthly Insulin Cost | Annual Insulin | Availability |
|---|---|---|---|
| Medicare Part D (IRA cap) | $35/month max | $420 | All Medicare Part D enrollees |
| Lilly/Novo/Sanofi $35 cap programs | $35/month | $420 | All U.S. residents incl. uninsured |
| Medicaid | $0–$3/month | $0–$36 | Low-income eligible patients |
| Commercial insurance (copay) | $25–$100/month | $300–$1,200 | Insured patients on formulary |
| Walmart OTC human insulin | $25–$50/month | $300–$600 | Anyone, no Rx needed |
| Biosimilar (self-pay) | $150–$250/month | $1,800–$3,000 | Self-pay, no program |
| Brand-name (self-pay, no program) | $250–$600/month | $3,000–$7,200 | Self-pay, no assistance |
The Inflation Reduction Act: What Changed for Medicare Patients
The Inflation Reduction Act of 2022 capped insulin cost-sharing for Medicare beneficiaries at $35 per month per covered insulin product. This took effect January 1, 2023 for Medicare Part D and July 1, 2023 for Medicare Part B (insulin pump users). The $35 cap applies regardless of whether the patient has met their deductible. Before this law, some Medicare patients paid $100 to $200+ per month for insulin. Patients needing both a basal and bolus insulin now pay no more than $70/month total ($35 x 2 products). Certain Medicare Advantage plans have different structures; always verify with your specific plan.
💡 Get the $35 Cap Without Insurance: If you have NO insurance and use Lilly insulin (Humalog, Basaglar, Lispro, Humulin): visit InsulinAffordability.com or call 1-833-808-1234 to download a free Insulin Value Program savings card. Take the card to your pharmacy and pay $35/month — the program is available to all uninsured U.S. residents. No income requirement. Novo Nordisk and Sanofi have similar programs for their insulins. If you’re paying more than $35/month for insulin from any of these three manufacturers, you may be missing savings you’re entitled to.
Walmart OTC Human Insulin: $25 Per Vial, No Prescription
Walmart pharmacies sell three human insulin types over-the-counter without a prescription under the ReliOn brand: Novolin R (regular, short-acting), Novolin N (NPH, intermediate-acting), and Novolin 70/30 (premix). Price: $25 per 10mL vial at Walmart. These are older human insulins (not modern analogs) that have different pharmacokinetic profiles — they work more slowly and have different meal-timing requirements than modern analog insulins. Most endocrinologists do not recommend switching from analog to human insulin without medical supervision, as the dosing and timing are different. For some patients who primarily use human insulin, this represents significant savings. Always consult your doctor before switching insulin types.
Annual Diabetes Management Costs Beyond Insulin
| Cost Item | Without Insurance | With Insurance | Notes |
|---|---|---|---|
| Insulin (manufacturer cap/Medicare) | $35–$70/mo | $35–$70/mo | Per covered product |
| CGM sensors (Dexcom G7, Libre 3) | $150–$300/mo | $25–$75/mo | Most T1D use CGM daily |
| Insulin pump supplies (if applicable) | $250–$500/mo | $50–$150/mo | Infusion sets, cartridges |
| Pen needles / syringes | $15–$30/mo | $5–$15/mo | Monthly supply |
| Backup test strips (lancets) | $25–$50/mo | $5–$20/mo | Even CGM users need backup |
| Endocrinologist visits (4x/year) | $600–$1,200/yr | $100–$400/yr | Specialist copay |
| A1C and monitoring labs (4x/year) | $200–$500/yr | $40–$150/yr | Essential quarterly test |
Frequently Asked Questions
With the $35 manufacturer cap (Lilly/Novo/Sanofi, all patients including uninsured): $35/month. Medicare Part D (IRA cap): $35/month max per covered product. Medicaid: $0 to $3/month. Commercial insurance copay: $25 to $100/month. Walmart OTC human insulin: $25 to $50/month (no Rx). Biosimilar self-pay: $150 to $250/month. Brand-name self-pay without any program: $250 to $600/month depending on regimen complexity.
Yes. Eli Lilly's Insulin Value Program caps ALL Lilly insulins at $35/month for all U.S. residents regardless of insurance status. Visit InsulinAffordability.com or call 1-833-808-1234 for a free savings card — no income requirement for the $35 cap. Novo Nordisk and Sanofi have similar programs. These programs were expanded in 2023 to cover all patients, not just those who couldn't afford insulin. If you're paying more than $35/month for Lilly, Novo Nordisk, or Sanofi insulin, you are likely missing this benefit.
The Inflation Reduction Act (IRA) of 2022 capped insulin cost-sharing for Medicare beneficiaries at $35 per month per covered insulin product. Effective Jan 1, 2023 for Medicare Part D and July 1, 2023 for Medicare Part B (insulin pumps). The cap applies even before the deductible is met. Before the IRA, some Medicare patients paid $100 to $300+ per month for insulin. The cap applies to each covered insulin on the formulary — patients needing two insulins pay a maximum of $70/month total.
Walmart sells Novolin R (regular), Novolin N (NPH), and Novolin 70/30 over-the-counter for $25 per vial — no prescription required. These are human insulins (not modern analogs) available at Walmart pharmacies without an Rx. They have slower onset and different timing requirements than analog insulins. Consult your doctor before switching insulin types; human and analog insulins are not interchangeable without dose and timing adjustments. For patients already using human insulin, Walmart provides the lowest-cost access.
Yes. Medicare Part D covers most insulins on the plan formulary with a $35/month cap per covered insulin (IRA, effective Jan 2023). Medicare Part B covers insulin delivered by insulin pumps covered as durable medical equipment, also capped at $35/month (IRA, effective July 2023). Part D covers syringe/pen insulin; Part B covers pump insulin. Standard copay structure (after the $35 cap is in place) does not require deductible to be met first. Compare Medicare Part D plans annually at Medicare.gov during Open Enrollment to ensure your insulin is on the formulary.
Biosimilar insulins are FDA-approved versions highly similar to brand-name biologic insulins, therapeutically equivalent and interchangeable (for FDA-designated interchangeables). Examples: Basaglar (biosimilar Lantus): typically 15 to 25% less than Lantus. Admelog (biosimilar Humalog): 15 to 25% savings. Semglee (FDA-approved interchangeable for Lantus): significant additional savings. Self-pay biosimilar cost: $150 to $220/vial vs $280 to $350/vial brand-name. With manufacturer $35 cap or insurance, both brands and biosimilars are similarly affordable — biosimilar savings matter most for self-pay patients not enrolled in assistance programs.
Annual diabetes management for a Type 1 patient with manufacturer $35 cap: Insulin $420, CGM sensors $2,400 (without insurance), pen needles $200, backup strips $360, endocrinologist 4 visits $800, A1C labs $200 = $4,380/year. With insurance covering CGM and labs: Insulin $420, CGM $600, needles $200, strips $240, endocrinologist visits $200, labs $150 = $1,810/year. For Type 2 patients on basal insulin only without pump or CGM: $420 to $1,200/year for insulin + $500 to $1,500 for other supplies and monitoring.
Yes. Several programs provide free insulin: Novo Nordisk Patient Assistance Program: free insulin for uninsured patients with income at or below 400% FPL ($60,240/year for a single adult in 2024). Lilly Cares Foundation: free Lilly insulin for eligible low-income patients. Sanofi Patient Connection: reduced-cost or free insulin for qualifying patients. FQHCs (community health centers): sliding-scale pricing including near-free insulin for qualifying low-income patients. Use NeedyMeds.org to find current patient assistance program eligibility for specific insulin products.
Approximately 26 states have enacted insulin cost-sharing caps for insured patients, typically limiting copays to $25 to $50 per month. These caps apply to state-regulated insurance plans (not self-insured employer plans or federal programs). States with insulin caps include Colorado ($100/month or 30-day supply cap), California, New York, and many others. However, with the Big Three manufacturer $35/month programs now available to all patients including the uninsured, state caps are less critical than when manufacturer programs were more limited. Always check your specific state's current law at your state insurance commissioner's website.
Federally Qualified Health Centers (FQHCs) provide healthcare on a sliding-scale fee basis and access insulin at 340B Program prices, making insulin significantly cheaper for their patients. To find an FQHC: visit findahealthcenter.hrsa.gov (official HRSA locator), search by zip code, and call to confirm insulin availability and pricing. FQHCs serve patients regardless of insurance status or ability to pay. For qualifying patients, insulin at FQHCs may cost $0 to $40/month. Some FQHCs also provide insulin pumps and CGMs at reduced cost.
New insulin pump cost without insurance: $5,500 to $10,000+ for the pump device. Annual pump supplies (infusion sets, cartridges, reservoirs) add $3,000 to $6,000/year. Total first-year pump cost without insurance: $8,500 to $16,000. With insurance, pumps are covered as durable medical equipment under Part B for Medicare and typically covered under commercial insurance DME benefits — patient responsibility varies widely by plan (20% coinsurance after deductible is common). CGM integration (hybrid closed-loop systems like Omnipod 5 and Tandem Control-IQ) requires a compatible CGM, adding CGM costs. Pump users on Medicare pay a maximum of $35/month for their pump insulin under the IRA cap.
Type 1 diabetes typically requires both basal and bolus insulin (2 to 3+ injections/day or continuous insulin pump) plus a CGM for safe management. Annual insulin cost: $420 (with $35 cap) to $7,200+ (brand self-pay, no program). Type 2 diabetes often starts with basal insulin only (1 injection/day) and may not require bolus insulin initially. Annual insulin cost: $35/month ($420/year) with manufacturer cap for 1 vial/month. The ADA 2024 report estimates total annual cost of diagnosed diabetes (not just insulin) at $12,722 per year on average, including medical costs and lost productivity.
Related Calculators
Popular Calculators
Stripe Fee Calculator
Finance
Pain & Suffering
Legal
TDEE Calculator
Health
Roofing Calculator
Construction
GPA Calculator
Education
Mortgage Refinance
Finance
CPM Calculator
Marketing
Markup Calculator
Finance
Bmi Calculator Women
Health
Pulmonary Artery Pressure Calculator
Health
Veterinary Cost Estimator
Health
Vo2 Max Calculator
Health